Skip to main content

Practice Management

Practice Management

Cost and Drug Utilization Patterns Associated with the Management of Rosacea

Caroline Helwick

Practice Management, Pulmonary

Rehospitalization Is Driving Costs in Pulmonary Arterial Hypertension

Practice Management

Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR

Andrew Paris, MBA, Chris M. Kozma, PhD, Wing Chow, PharmD, MPH, Anisha M. Patel, MS, Samir H. Mody, PharmD, MBA, Myoung S. Kim, PhD, MBA

Stakeholder Perspective

Can Substituting Generic Drugs with Brand-Name Agents for Acute Pain Postsurgery Help to Deliver Cost-Effective, Quality Care?

by Matthew Mitchell, PharmD, MBA, FAMCP

Practice Management

Development of a Medicare Beneficiary Comprehension Test: Assessing Medicare Part D Beneficiaries’ Comprehension of Their Benefits

Meghana Aruru, PhD, MBA, BSPharm, J. Warren Salmon, PhD

Stakeholder Perspective

Understanding the Options: An Essential Ingredient in Our Evolving Healthcare System

by Joseph R. Antos, PhD

Practice Management

The Economics of Biosimilars

Erwin A. Blackstone, PhD, Joseph P. Fuhr, Jr, PhD

Stakeholder Perspective

Modeling the Future Economic Impact of Biosimilars’ Entry into the US Market

by Grant D. Lawless, RPh, MD, FACP

Practice Management

The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population

Jonah Broulette, ASA, MAAA, Holly Yu, MSPH, Kosuke Iwasaki, FIAJ, MAAA, Reiko Sato, PhD, Bruce S. Pyenson, FSA, MAAA

Stakeholder Perspective

CAP Is a Burden for All Ages—Prevention Strategies Are Key

by F. Randy Vogenberg, PhD, FASHP

Practice Management

Technological Changes Can Transform Medicine by 2020: A Conversation with the Futurist Jim Carroll

Rosemary Frei, MSc

Practice Management

Impact of Glycemic Control on Healthcare Resource Utilization and Costs of Type 2 Diabetes: Current and Future Pharmacologic Approaches to Improving Outcomes

Mary Ann Banerji, MD, FACP, Jeffrey D. Dunn, PharmD, MBA, Jeffrey A. Bourret, PharmD

Stakeholder Perspective

Innovation in Patient Engagement and Management Is Critically Needed to Change Current Trends in Type 2 Diabetes

Practice Management

Communication Strategies Must Be Tailored to a Medication’s Targeted Population: Lessons from the Case of BiDil

Chamika Hawkins-Taylor, MHA, PhD, Angeline M. Carlson, PhD

Stakeholder Perspective

Much More than Biomarkers: Sociodemographic Variables in Personalized Medicine

by Michael F. Murphy, MD, PhD

Practice Management

Yet Another Blow to the Medicaid Expansion

Igor Gorlach, JD, MPH, Ross D. Margulies, JD, MPH

Page 17 of 32
Results 161 - 170 of 318